Dalia Ibrahim Ramadan

Dalia Ibrahim Ramadan

Auto-generated profile, based on publicly available information

Dalia Ibrahim Ramadan

Department of Clinical and Chemical Pathology, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2011 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
UFUsama M. Fouda
Usama M. Fouda
ASAhmed M. Sayed
Ahmed M. Sayed
AAAbdel‐Megid A. Abdou
Abdel‐Megid A. Abdou
DRDalia I. Ramadan
Dalia I. Ramadan
IFIman M. Fouda
Iman M. Fouda
MZMahmoud M. Zaki
Mahmoud M. Zaki

20 January 2016 in Molecular Diagnosis & Therapy
Verified
Journal Article
Closed access
PDF file
RARadwa Marawan AbdelHalim
Radwa Marawan AbdelHalim
DRDalia Ibrahim Ramadan
Dalia Ibrahim Ramadan
RZReham Zeyada
Reham Zeyada
ANAhmed Soliman Nasr
Ahmed Soliman Nasr
IMIman Atef Mandour
Iman Atef Mandour

1 November 2010 in Journal of Obstetrics and Gynaecology
Verified
Journal Article
Closed access
PDF file
UFU. M. Fouda
U. M. Fouda
ASA. M. Sayed
A. M. Sayed
DRD. I. Ramadan
D. I. Ramadan
IFI. M. Fouda
I. M. Fouda
The aim of this randomised controlled trial was to compare efficacy and safety of two doses of low molecular weight heparin (enoxaparin) in pregnant women with a history of recurrent abortion secondary to antiphospholipid syndrome. A total of 60 women with a minimum of three consecutive abortions before 10 weeks' gestation and positive lupus anticoagulant and/or anticardiolipin antibodies on at least two occasions at least 12 weeks apart were randomised into two groups based on computer generated randomisation list concealed in opaque envelopes. Pregnant women were treated with enoxaparin 40 mg plus low dose aspirin (LDA) (n = 30) or enoxaparin 20 mg plus LDA (n = 30). The live birth rate was 76.67% in enoxaparin 40 mg group and 70% in enoxaparin 20 mg group (p value = 0.559). There were no significant differences between both groups with respect to neonatal outcome, obstetric and maternal complications during pregnancy or puerperium. No cases of severe bleeding, thrombocytopenia or spontaneous fractures were reported in both groups.

1 March 2016 in Arab Journal of Gastroenterology
Verified
Journal Article
Closed access
WZWalaa M. Abu Zeid
Walaa M. Abu Zeid
DRDalia I. Ramadan
Dalia I. Ramadan
MSMohamed Shemis
Mohamed Shemis

1 January 2014 in Clinical Biochemistry
Verified
Journal Article
Closed access
Mohamed A. ElmonemMohamed A. Elmonem
Mohamed A. Elmonem
DRDalia I. Ramadan
Dalia I. Ramadan
Marianne Samir Makboul IssacMarianne Samir Makboul Issac
Marianne Samir Makboul Issac
LSLaila A. Selim
Laila A. Selim
SESara M. Elkateb
Sara M. Elkateb

30 April 2012 in Hepatitis Monthly
Verified
Journal Article
Open access
PDF file
MSMohamed Shemis
Mohamed Shemis
DEDina Mohamed El-Abd
Dina Mohamed El-Abd
DRDalia Ibrahim Ramadan
Dalia Ibrahim Ramadan
MEMohamed Ibrahim El-Sayed
Mohamed Ibrahim El-Sayed
BGBassem Shenoda Guirgis
Bassem Shenoda Guirgis
HAHassan Mohamed El- Said Azzazy
Hassan Mohamed El- Said Azzazy
Evaluation of Multiplex Nested Polymerase Chain Reaction for Routine Hepatitis C Virus Genotyping in Egyptian Patients - Hepatitis Monthly - 2012 - Kowsar